References
- Haberkorn D, Strauss LG, Dimitrakopoulou A, et al : Fluoro-deoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med. 1993 ; 34 : 12-17
- Kitagawa Y, Sadato N, Azurna H, et al : FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms. J Nucl Med. 1999 ;40 : 1132-1137
- Lowe VJ, Dunphy FR, Varvares M, et al : Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography. Head Neck. 1997;19:666-674. https://doi.org/10.1002/(SICI)1097-0347(199712)19:8<666::AID-HED4>3.0.CO;2-3
- Kunkel M, Forster GJ, Reichert TE, et al : Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma. Oral Oncology. 2003 ; 39 : 170-177 https://doi.org/10.1016/S1368-8375(02)00087-8
- Brun E, Kjellen E, Tennvall J, et al : FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck. 2002 : 24 (2) : 127-135
- Nuutinen J, Jyrkkio S, Lehikoinen P, Lindholm P, Minn H : Evaluation of early response to radiotherapy in head and neck cancer measured with [11-C] methionine-positron emission tomography. Radiother Oncol. 1999 ; 52 : 225-232 https://doi.org/10.1016/S0167-8140(99)00091-2
- Janson T, Westlin JE, Ahlstrom H, Lilja A, Langstrom B, Bergh J : Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer : A method for early therapy evaluation? J Clin Oncol. 1995 ;13 : 1470-1477
- Schelling M, Avril N, Nahrig W, et al : Positron emission tomography using 18F Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Cin Oncol. 2000 ; 18 : 1689-1695
- Schulte M, Brecht Krauss D, Werner M, et al : Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG-PET. J Nucl Med. 1999 ; 40 : 1637-1643
- Romer W, Hanauske A-R, Ziegler S, et al : Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood. 1998 ; 91 : 4464-4471
- Brock C, Young H, O'Reilly S, et al : Early evaluation of tumor metabolic response using 18 F-fluorodeoxyglucose and positron emission tomography : a pilot study after the phase 11 chemotherapy schedule for temozolamide in recurrent high grade gliomas. Br J Cancer. 2000 ; 82 : 608-615 https://doi.org/10.1054/bjoc.1999.0971
- Fischbein NJ, Assar OS, Caputo GR, et al : Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. Am J Neuroradiol. 1998 ; 19 : 1189-1196
- Kao CH, ChangLai SP, Chieng PD, Yen RF, Yen TC : Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol. 1998 ; 16 : 3550-3555 https://doi.org/10.1200/JCO.1998.16.11.3550
- Lapela M, Grenman R, Kurki T, et al : Head and neck cancer : detection of recurrence with PET and 2[F-18]fluoro-2-dexoy-D-glucose. Radiology. 1995 ; 197 : 205-211
- Greven KM, Williams DW 3rd, Keyes JW Jr, et al : Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer. Int J Radiat Oncol. 1994 ; 29 : 841-845 https://doi.org/10.1016/0360-3016(94)90574-6
- Greven KM, Williams DW 3rd, Keyes JW Jr, et al : Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer. 1994 ; 74 : 1355-1359 https://doi.org/10.1002/1097-0142(19940815)74:4<1355::AID-CNCR2820740428>3.0.CO;2-I
- Mitsuhashi N, Hayakawa K, Hasegawa M, et al : Clinical FDGPET in diagnosis and evaluation of radiation response of patients with nasopharyngeal tumor. Anticancer Res. 1998 ;18 : 2827-2832
- Eichhorn T, Schroeder HG, Glanz H, Schwerk WB : Histologically controlled comparison of palpation and sonography in the diagnosis of cervical lymph node metastases. Laryngol Rhinol Otol. 1987 ; 66 : 266-274 https://doi.org/10.1055/s-2007-998651
- Adams S, Baum RP, Stuckensen T, Bitter K, Hor G : Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 1998 ; 25 : 1255-1260 https://doi.org/10.1007/s002590050293
- Laubenbacher C, Saumweber D, Wagner-Manslau C, et al : Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med. 1995 ; 36 : 1747-1757
- Haberkorn D, Strauss LG, Reisser C, et al : Glucose uptake, perfusion, and cell proliferation in head and neck tumors : relation of positron emission tomography to flow cytometry. J Nucl Med. 1991 ; 32 : 1548-1555